QT replacement plan

FDA has completed validation of a preclinical assay system that could replace clinical QT testing, a move it hopes will lower development costs and reduce false alarms of arrhythmia risk.

The question for drug developers is when the new tests will be required for all IND submissions, and how long they’ll have to be performed on top of existing QT testing. ...